OncoSec Medical, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Services » Medical Or Nursing Services
GHGuardant Health, Inc. 0.67%83.220.0%$112.10m
DVADaVita, Inc. 7.13%88.263.2%$104.08m
SDCSmileDirectClub, Inc. 4.01%8.810.0%$91.20m
LHCGLHC Group, Inc. -0.72%158.172.9%$56.83m
AMEDAmedisys, Inc. -0.20%175.6811.5%$53.98m
CHEChemed Corp. 1.03%456.8910.1%$52.57m
ONEM1Life Healthcare, Inc. 2.75%32.870.0%$48.35m
NVTAInvitae Corp. 3.96%17.332.0%$36.61m
NTRANatera, Inc. -1.60%40.541.3%$36.08m
NEONeoGenomics, Inc. 0.07%27.545.7%$28.58m
MDMEDNAX, Inc. 12.64%19.1611.1%$26.25m
ACHCAcadia Healthcare Co., Inc. 4.44%30.1227.1%$21.37m
ENSGThe Ensign Group, Inc. 6.97%47.175.7%$18.45m
TVTYTivity Health, Inc. 5.27%11.389.0%$15.94m
ADUSAddus HomeCare Corp. -1.63%97.041.0%$12.26m

Company Profile

OncoSec Medical, Inc. is a biotechnology company, which engages in designing, developing, and commercializing therapies for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an electroporation device, with the aim of reversing the immunosuppressive microenvironment in the treated tumor. The company was founded by Avtar S. Dhillon and Punit S. Dhillon on February 8, 2008 and is headquartered inPennington, NJ.